Guideline-based management of acute respiratory failure and acute respiratory distress syndrome. 2023

Seitaro Fujishima
Center for General Medicine Education, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku-Ku, Tokyo, 160-8582, Japan. fujishim@keio.jp.

Acute respiratory failure (ARF) is defined by acute and progressive hypoxemia caused by various cardiorespiratory or systemic diseases in previously healthy patients. Among ARF, acute respiratory distress syndrome (ARDS) is a serious condition with bilateral lung infiltration, which develops secondary to a variety of underlying conditions, diseases, or injuries. This review summarizes the current standard of care for ARF and ARDS based on current major guidelines in this field. When administering fluid in patients with ARF, particularly ARDS, restrictive strategies need to be considered in patients without shock or multiple organ dysfunction. Regarding oxygenation targets, avoiding excessive hyperoxemia and hypoxemia is probably a reasonable choice. As a result of the rapid spread and accumulation of evidence for high-flow nasal cannula oxygenation, it is now weakly recommended for the respiratory management of ARF in general and even for initial management of ARDS. Noninvasive positive pressure ventilation is also weakly recommended for the management of certain ARF conditions and as initial management of ARDS. Low tidal volume ventilation is now weakly recommended for all patients with ARF and strongly recommended for patients with ARDS. Limiting plateau pressure and high-level PEEP are weakly recommended for moderate-to-severe ARDS. Prone position ventilation with prolonged hours is weakly to strongly recommended for moderate-to-severe ARDS. In patients with COVID-19, ventilatory management is essentially the same as for ARF and ARDS, but awake prone positioning may be considered. In addition to standard care, treatment optimization and individualization, as well as the introduction of exploratory treatment, should be considered as appropriate. As a single pathogen, such as SARS-CoV-2, exhibits a wide variety of pathologies and lung dysfunction, ventilatory management for ARF and ARDS may be better tailored according to the respiratory physiologic status of individual patients rather than the causal or underlying diseases and conditions.

UI MeSH Term Description Entries

Related Publications

Seitaro Fujishima
October 2016, Tuberculosis and respiratory diseases,
Seitaro Fujishima
January 2017, Tuberculosis and respiratory diseases,
Seitaro Fujishima
February 2000, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace,
Seitaro Fujishima
March 1996, Respirology (Carlton, Vic.),
Seitaro Fujishima
June 2020, American family physician,
Seitaro Fujishima
February 2012, American family physician,
Seitaro Fujishima
March 2012, Minerva anestesiologica,
Seitaro Fujishima
February 2011, Current opinion in critical care,
Copied contents to your clipboard!